What are the barriers towards cervical cancer screening for vulnerable women? A qualitative comparative analysis of stakeholder perspectives in seven European countries
- PMID: 38760040
- PMCID: PMC11103196
- DOI: 10.1136/bmjopen-2023-079921
What are the barriers towards cervical cancer screening for vulnerable women? A qualitative comparative analysis of stakeholder perspectives in seven European countries
Abstract
Objectives: The aim of this study was to map and compare stakeholders' perceptions of barriers towards cervical cancer screening for vulnerable women in seven European countries.
Design: In Collaborative User Boards, stakeholders were invited to participate to identify barriers towards participation in cervical cancer screening.
Setting: The study is nested in the European Union-funded project CBIG-SCREEN which aims to tackle inequity in cervical cancer screening for vulnerable women (www.cbig-screen.eu). Data collection took place in Bulgaria, Denmark, Estonia, France, Italy, Portugal and Romania.
Participants: Participants represented micro-level stakeholders covering representatives of users, that is, vulnerable women, meso-level stakeholders covering healthcare professionals and social workers, and macro-level stakeholders covering programme managers and decision-makers.
Methods: Across the seven countries, 25 meetings in Collaborative User Boards with a duration of 2 hours took place between October 2021 and June 2022. The meetings were video recorded or audio recorded, transcribed and translated into English for a qualitative framework analysis.
Results: 120 participants took part in the Collaborative User Boards. Context-specific barriers were related to different healthcare systems and characteristics of vulnerable populations. In Romania and Bulgaria, the lack of a continuous screening effort and lack of ways to identify eligible women were identified as barriers for all women rather than being specific for women in vulnerable situations. The participants in Denmark, Estonia, France, Italy and Portugal identified providers' lack of cultural and social sensitivity towards vulnerable women as barriers. In all countries, vulnerable women's fear, shame and lack of priority to preventive healthcare were identified as psychological barriers.
Conclusion: The study provides an overview of stakeholders' perceived barriers towards vulnerable women's cervical cancer screening participation in seven European countries. The organisation of healthcare systems and the maturity of screening programmes differ between countries, while vulnerable women's psychological barriers had several similarities.
Keywords: Gynaecological oncology; Health Equity; Health Services Accessibility; PREVENTIVE MEDICINE; PUBLIC HEALTH; QUALITATIVE RESEARCH.
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
How can cervical screening meet the needs of vulnerable women? A qualitative comparative study with stakeholder perspectives from seven European countries.BMJ Open. 2025 Jan 25;15(1):e090631. doi: 10.1136/bmjopen-2024-090631. BMJ Open. 2025. PMID: 39863407 Free PMC article.
-
Factors associated with cervical cancer screening participation among migrant women in Europe: a scoping review.Int J Equity Health. 2020 Sep 11;19(1):160. doi: 10.1186/s12939-020-01275-4. Int J Equity Health. 2020. PMID: 32917224 Free PMC article.
-
Controversies about cervical cancer screening: A qualitative study of Roma women's (non)participation in cervical cancer screening in Romania.Soc Sci Med. 2017 Jun;183:48-55. doi: 10.1016/j.socscimed.2017.04.040. Epub 2017 Apr 26. Soc Sci Med. 2017. PMID: 28460211
-
"Cervical cancer screening: awareness is not enough". Understanding barriers to screening among women in West Cameroon-a qualitative study using focus groups.Reprod Health. 2021 Jul 9;18(1):147. doi: 10.1186/s12978-021-01186-9. Reprod Health. 2021. PMID: 34243778 Free PMC article.
-
Women's preferences and experiences of cervical cancer screening in rural and remote areas: a systematic review and qualitative meta-synthesis.Rural Remote Health. 2019 Oct;19(4):5190. doi: 10.22605/RRH5190. Epub 2019 Oct 23. Rural Remote Health. 2019. PMID: 31640391
Cited by
-
Accuracy of real-time PCR assays for human papillomavirus using urine samples: a systematic review and meta-analysis.J Clin Microbiol. 2025 May 14;63(5):e0135224. doi: 10.1128/jcm.01352-24. Epub 2025 Mar 31. J Clin Microbiol. 2025. PMID: 40162806 Free PMC article.
-
Mortality of Three Major Gynecological Cancers in the European Region: An Age-Period-Cohort Analysis from 1992 to 2021 and Predictions in a 25‑Year Period.Ann Glob Health. 2025 Jun 10;91(1):30. doi: 10.5334/aogh.4688. eCollection 2025. Ann Glob Health. 2025. PMID: 40528926 Free PMC article.
-
Enhancing Cervical Cancer Screening with 7-Type HPV mRNA E6/E7 Testing on Self-Collected Samples: Multicentric Insights from Mexico.Cancers (Basel). 2024 Jul 8;16(13):2485. doi: 10.3390/cancers16132485. Cancers (Basel). 2024. PMID: 39001547 Free PMC article.
-
How can cervical screening meet the needs of vulnerable women? A qualitative comparative study with stakeholder perspectives from seven European countries.BMJ Open. 2025 Jan 25;15(1):e090631. doi: 10.1136/bmjopen-2024-090631. BMJ Open. 2025. PMID: 39863407 Free PMC article.
References
-
- Maguire SK, Sundseth H, Keenan L. Women and Cervical cancer in the EU. European Institute for women’s health policy brief: European Institute for Women’s Health. 2017. Available: https://eurohealth.ie/wp-content/uploads/2018/05/Cervical-Cancer.pdf